On August 7, the DOJ and four state attorneys general announced a settlement to resolve their challenge to the $3.3 billion ...

JenaValve is in the process of obtaining FDA approval for the first transcatheter aortic valve to address aortic ...

President Trump and the FTC just struck a decisive blow against the Democrat agenda to end gas-powered vehicles,” Republican ...

Investing.com -- Moody’s Ratings has affirmed Edwards Lifesciences Corporation ’s Baa2 ratings while revising the outlook to positive from stable, the credit rating agency announced Wednesday.

The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years. The rising geriatric ...

A lethal injection did not set off an implantable cardioverter defibrillator (ICD) shock in the Tennessee man who received ...

The heart valve devices market encompasses medical technologies used to repair or replace diseased aortic, mitral, tricuspid, ...

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

CHS is making another attempt to exit the Pennsylvania market and UnitedHealth Group struck a deal with the Justice Department to allow its acquisition of a home health and hospice care provider to ...

WASHINGTON - The Federal Trade Commission on Wednesday filed a federal lawsuit aimed at blocking the proposed merger of two medical device companies currently developing new treatments for a ...

The Federal Trade Commission filed a lawsuit to prevent Edward LifeSciences from acquiring JenaValve Technology, arguing the deal would stifle innovation in treatments for aortic regurgitation, a ...

A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing ...